Cargando…
Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer
Many signaling pathways, including the JAK/STAT3 pathway, are aberrantly activated and associated with ovarian cancer growth and progression. However, inhibition of STAT3 pathway alone was not sufficient to effectively block human ovarian cancer cell survival in vitro, which could be due to the acti...
Autores principales: | Wen, Wei, Han, Ernest S., Dellinger, Thanh H., Wu, Jun, Guo, Yuming, Buettner, Ralf, Horne, David A., Jove, Richard, Yim, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542771/ https://www.ncbi.nlm.nih.gov/pubmed/31141756 http://dx.doi.org/10.1016/j.tranon.2019.05.003 |
Ejemplares similares
-
Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
por: Wen, Wei, et al.
Publicado: (2015) -
Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer
por: Wen, Wei, et al.
Publicado: (2020) -
Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer
por: Han, Ernest S., et al.
Publicado: (2018) -
Spirooxindole Derivative SOID-8 Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells
por: Tian, Yan, et al.
Publicado: (2012) -
Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer
por: Yang, Chunmei, et al.
Publicado: (2013)